novo nordisk glp-1 receptor agonist weight management diabetes treatments How Agonists Evolved from to Loss Glucagon-Like Peptide-1 Based Therapies: A

The UAB study shows that 91 percent of exposures are due to mistakes that happen when patients are administering the treatments on themselves, with 21 percent of those exposures related to errors on initial use of the pen

2019;10 doi: 10.3389/fendo.2019.00155

Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials

When people eat certain types of fiber, like that found in fruits, vegetables, and whole grains, their gut bacteria break it down into short-chain fatty acids

Lundgren JR et al

Opt for healthy unsaturated fats (e.g., olive oil, avocado, fatty fish), which slow digestion and may enhance GLP-1 release